p-Nonylphenol (p-NP) is a metabolite of alkylphenol ethoxylates used as surfactants in the manufacturing industry. Although it is reported to have estrogenic activity and to be transferred from the mother to the embryo, no data is available on its effects on the development of the human placenta. In the present study, we investigated Estrogen Receptors (ERs) expression in the first trimester human placenta. Using an in vitro model of chorionic villous explants, we then compared the effects of p-NP and 17β-estradiol (17β-E2). Finally, a trophoblast-derived choriocarcinoma cell line, BeWo, was used as a model of trophoblast cell differentiation. These findings suggest that the human trophoblast may be highly responsive to p-NP and raise concern about maternal exposure in early gestation.
Introduction
Increasing evidence suggests that exposure to certain man-made chemicals present in the environment may interfere with endocrine function in humans and wildlife (Safe, 1995 Weiss, 1998 . Alkylphenol ethoxylates are a class of non-ionic surfactants introduced in the 1940s and used in detergents, paints, pesticides, personal care products and plastics (Soto et al., 1991; White et al., 1994) . The most commonly used alkylphenol ethoxylates in consumer products have nine carbon atoms with branched alkyl chains and are thus known as nonylphenol ethoxylates. These chemicals are discharged into aquatic environments with urban and industrial wastewater. Here they are broken down microbially into nonylphenol ethoxylate by-products and the final degradation intermediate nonylphenol (Rudel et al., 2003; White et al., 1994) . These metabolites are also used as intermediates in the chemical industry (Müller and Schlatter, 1998) .
Human exposure to p-nonylphenol (p-NP) may occur by cutaneous absorption, ingestion of contaminated food or water and inhalation (Guenther et al., 2003; Monteiro-Riviere et al., 2000) .
Great concern has been expressed about this compound, after Soto et al., (1991) , accidentally found that p-NP, released by polystyrene, induced progesterone receptor and cell proliferation in estrogendependent breast cancer cells (MCF-7). Estrogenic activity of p-NP has been then investigated in a number of in vitro and in vivo studies. By binding to Estrogen Receptors (ERs), p-NP may disrupt normal endocrine function, promoting reproductive failure and carcinogenesis in estrogen-sensitive tissues (Blair et al., 2000; Sonnenschein and Soto, 1998) . p-NP acts directly via the ERs, displacing 17β-estradiol (17β-E2) from human cell line estrogen receptors (Soto et al., 1995; White et al., 1994) and specifically inhibiting binding of 17β-E2 to ERs (Kwack et al., 2002) .
Interestingly, in vivo studies have shown that maternal exposure to p-NP resulted in an increase in uterine calbinding-D 9k (CaBP-9k) expression in maternal and neonatal rat uteri (Hong et al., 2004; Kwack et al., 2002) . These and other studies suggest that p-NP can cross the placenta and cause reproductive and developmental toxicity. Reports on several endocrine disruptor chemicals (bromodichloromethane, organochlorine compounds) describe the effect of these substances on at Pennsylvania State University on February 23, 2013 http://toxsci.oxfordjournals.org/ Downloaded from 4 human trophoblast (Chen et al., 2003; Chen et al., 2004; Hamel et al., 2003) while, no functional studies regarding the effects of p-NP on the placenta have yet been reported.
Previous studies show that the placenta is an estrogen-target tissue and that estrogens have important physiological roles in regulating functional differentiation of the placental villous trophoblast (Bukovsky et al., 2003a; Cronier et al., 1999; Rama et al., 2004) . Expression of estrogen receptor (ER) α and β protein was recently demonstrated in the human placenta at term (Bukovsky et al., 2003b) . Expression of ERα, β and γ mRNA was also recently reported to increase in the placenta throughout gestation (Fujimoto et al., 2005) .
The aim of the present study was: a) to investigate protein expression of ERs in first trimester human placentas; b) to compare the effects of p-NP and 17β-E2 on trophoblast differentiationapoptosis by an in vitro model of chorionic villous explants; c) to verify the role of p-NP in a trophoblast-derived choriocarcinoma cell line, BeWo.
We demonstrate that first trimester placenta, like the placenta at term, expresses estrogen receptor proteins α and β and that p-NP exerts estrogen-like activity on trophoblast, inducing hCG secretion and caspase-3 activity, two main markers of trophoblast differentiation and apoptosis (StraszewskiChavez et al., 2005) .. Unexpectedly, at equimolar concentrations of 10 -9 M, the effect of p-NP was significantly greater and longer lasting than that of 17β-E2. Isolation and treatment of chorionic villous explants. Chorionic villous explant cultures were established from 7-9 week human placentas. Villous explants were dissected as described by Caniggia et al., (1997) . Briefly, small fragments of villous tips (15-20 mg wet weight) were placed on Millicell CM culture dish inserts (Millipore Corp, Bedford, MA), previously coated with 180 µL undiluted matrigel (Collaborative Research, Inc., Bedford, MA) and inserted in 24-well plates.
Explants were cultured in serum-free DMEM/F12 without phenol red (Gibco, Grand Island, NY) supplemented with 100 U/mL penicillin/streptomycin and 2 mM L-glutamine (Sigma Chemical Co, St. Louis, MO). Explant cultures were incubated overnight at 37°C in 5% CO 2 for attachment to the matrigel. The next day the culture medium was replaced with medium supplemented with 17β-estradiol (10 -9 M) (Sigma Chemical Co) or p-NP (10 -9 M), both dissolved in 0.1% ethanol, or with medium plus ethanol (controls). This concentration was selected far below the levels found in human samples (Kawaguchi et al. 2004; Inoue et al. 2000; Tan and Nohd, 2003) .
At predetermined incubation times (4, 24, 48, 72 hours), explants were removed from matrigel and washed in PBS. Part of each was frozen and stored at -80°C until processing for western blot analysis for ERs and caspase-3 expression. Culture medium was stored at -80°C until assay for β-hCG. 
Results

Expression of estrogen receptors in human placental tissue
Western blot analysis performed in first trimester (7-12 weeks) and term placental tissues revealed expression of ERα corresponding to the three known isoforms of 67 kDa, 46 kDa and 39 kDa (Denger et al., 2001 ) ( Figure 1A ). Analysis using antibody against ERβ showed one band of 55 kDa ( Figure 1B) . Immunohistochemistry in first trimester placenta sections showed strong expression of ERα in most chorionic villi, predominantly in the villous cytotrophoblast layer (Figure 2A ). Weak staining for ERα was also observed in some stromal cells of the villous core while no staining was observed in the syncytiotrophoblast (Figure 2A ). ERβ was localized in the syncytiotrophoblast layer and in only few cells of the cytotrophoblast; no staining was observed in the stromal region ( Figure   2B ).
Effects of p-NP and 17β β β β-E2 on first trimester villous explant cultures a. ER expression. Treatment of first trimester villous explant cultures with p-NP or 17β-E2 did not
produce significant differences compared to untreated cultures (controls) in the expression of ERs at 24, 48, 72 hours of incubation ( Figure 3A ). Western blot analysis showed expression of three bands for ERα at 67 kDa, 46 kDa and 39 kDa and a single band of 55 kDa for ERβ ( Figure 3B ). 
b. β-hCG concentration. β-hCG concentrations increased throughout incubation in treated (17β-E2 or p-NP) and untreated cultures (controls) (Figure 4
)
Apoptosis in BeWo cells
The cleaved forms of caspase-3 were found in p-NP treated cultures after one hour of treatment, whereas the caspase pathway only started to be activated in Forskolin and 17β-E2 cultures after 24 hours of incubation ( Figure 6 ). A sharp decrease in the pro-caspase form was also observed in p-NP-treated cultures after 6 hours. This 32 kDa band disappeared at 24 hours, suggesting complete cleavage of the protein (Figure 6 ). 
Discussion
Placental development is a key event for the success of pregnancy (Cross et al., 1994) .
Abnormalities in this event may lead to embryo developmental defects and death (Chaddha et al., 2004) . It is therefore important to identify factors that may interfere with the processes characterizing the first phases of pregnancy.
In our study we investigated whether p-NP, a metabolite of alkylphenol ethoxylates, may interfere with placental development. We demonstrated that the first trimester human placenta is an estrogentarget tissue expressing ERα and ERβ proteins. Using an in vitro model of chorionic villous explants, we then compared the effects of p-NP and 17β-E2 on first trimester human trophoblast.
Unlike cultures of isolated cells, this model has the advantage of preserving the topology of chorionic villi and maintaining the paracrine relations between the different cell components i.e.
cyto-and syncytio-trophoblast, trophoblast and stromal cells (Genbacev et al., 1992) . This is why it appears to be a good model for studying substances interfering with the homeostasis of placentation (Miller et al., 2005) . Using explant cultures from first trimester placentas, we demonstrated that p-NP mimics the effects of estrogens, increasing hCG secretion and cell apoptosis. Surprisingly, at equimolar concentrations of 10 -9 M, the effect of p-NP on hCG secretion was significantly greater than that of 17β-E2. Moreover, hCG secretion induced by p-NP increased up to 72 hours, whereas that induced by 17β-E2 peaked at 48 hours and was much lower by 72 hours. Evidence of cell apoptosis, shown by caspase-3 fragmentation, was detected at 72 hours in 17β-E2-and p-NPtreated tissues. Since the trophoblast is not the only cell component in villous explant cultures, we used a trophoblast-derived choriocarcinoma cell line, BeWo, to verify the effects of p-NP on cell differentiation, syncytialization and apoptosis. Previous reports showed that 17β-E2 treatment of BeWo cells induced differentiation by formation of multinucleate syncytial structures (Rama et al., 2004) . In this study we demonstrated that like 17β-E2 and forskolin, an inducer of cell differentiation, p-NP induces apoptosis in BeWo cells by cleavage of caspase-3. This effect was 12 observed after one hour of treatment with p-NP but not until 24 hours of treatment with 17β-E2 or forskolin. The apoptotic effect of p-NP by the caspase-3 pathway was recently demonstrated by Kudo et al., (2004) , in neural stem cells.
Taken together, the present findings indicate that p-NP exerts estrogen-like effects on first trimester placentas, affecting trophoblast differentiation and apoptosis. It is noteworthy that p-NP activity was greater and longer lasting than that of 17β-E2, suggesting that metabolism of p-NP in the trophoblast produces more stable and possibly more active metabolites.
Reports on in vitro systems e.g. recombinant yeast (Gaido et al., 1997) , primary trout hepatocytes (Flouriot et al., 1995) , MCF-7 cell line (Blom et al., 1998; Nagel et al., 1997) and transfected avian cells (White et al., 1994) , have shown that p-NP is about 1000 to 10 000 times less potent than 17β-E2. These studies also showed that the lowest effective concentrations of p-NP ranged from 100 nM to 1 µM. Our findings showing that p-NP is more potent than 17β-E2 at 10 -9 M, a concentration 100-1000 times less than that reported in other in vitro systems and at least than 1000 times lower that levels found in humans (Kawaguchi et al. 2004; Inoue et al. 2000; Tan and Nohd, 2003) . In fact concentration of 10 -9 M used in the present study is about 220.36 ng/L while the levels of p-NP detected in human samples vary from 0.3 to 221.7 ng/mL in plasma and blood samples (Kawaguchi et al., 2004; Inoue et al., 2000) and 15.17ng/mL in human cord boold samples (Tan and Nohd, 2003) suggesting that the trophoblast is extremely sensitive to this chemical.
In a recent paper, Bukovsky et al., (2003b) , showed that cell nuclei distant from the syncytiotrophoblast exhibited many ERα, while cell nuclei associated with the syncytiotrophoblast showed fewer ERα and some ERβ. The same authors also showed that estrogens may play a role, via ERα, in the stimulation of cytotrophoblast differentiation into syncytiotrophoblast (Bukovsky et al., 2003a) . In line with Bukovsky et al., (2003b) , we showed here that expression of ERα is mainly localized in the cytotrophoblast whereas that of ERβ is predominantly distributed in the 13 syncytiotrophoblast of the chorionic villi. Further studies are necessary to investigate the exact role of each isoform and the mechanism of action of estrogen-like compounds.
Differentiation of trophoblast into syncytiotrophoblast is a physiological event in placental development: the internal cytotrophoblast cells aggregate and their plasma membranes fuse (Potgens et al., 2002) . The syncytiotrophoblast, the external layer of villi, is an endocrine tissue producing hCG and placental lactogen. It also exchanges nutrients and gases between mother and fetus. The physiological turnover of placental epithelium produces syncytial knots which are shed apoptotically into the maternal bloodstream (Huppertz et al., 2002; Straszewski-Chavez et al., 2005) . Abnormal apoptosis, leading to faulty placentation, is involved in several gestational disorders including pre-eclampsia (Allaire et al., 2000; Crocker et al., 2004; ) .
Our finding of increased hCG secretion and cell apoptosis after exposure to the endocrine disruptor p-NP suggest that maternal exposure to this chemical may lead to aberrant or adaptive placental cell turnover in the uterus. This could cause early termination of pregnancy, gestational pathologies and fetal growth defects.
In conclusion, our data show that p-NP induces an estrogen-like response in first trimester human placenta by increasing trophoblast differentiation and apoptosis. The power of p-NP on early placenta even at low concentrations raises considerable concern about the implications of exposure to this chemical for the fetus and pregnancy. 
